PacBio and Covaris Unveil Integrated Workflow to Unlock HiFi Sequencing from FFPE Tumor Samples

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, and Covaris, a PerkinElmer company and leader in sample...

April 17, 2026 | Friday | News
Myriad Genetics Secures Japan Approval for MyChoice® as Companion Diagnostic in Prostate Cancer

- Myriad Genetics Inc.,  a leader in molecular diagnostic testing and precision medicine,announced that Japan’s Ministry of Health, Labour and...

April 16, 2026 | Thursday | News
Illumina and D3b Launch Landmark Pediatric Genomics Dataset to Accelerate Precision Medicine

Dataset will drive crucial insights to accelerate scientific discovery and ultimately improve pediatric patient care.  Illumina (NASDAQ: ILMN) and...

April 16, 2026 | Thursday | News
Cepheid And Oxford Nanopore Expand Collaboration To Advance Rapid Pathogen Genomic Workflows

Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research Cepheid, a Danaher company and a leader i...

April 16, 2026 | Thursday | News
Renaissance Pharma Secures FDA Fast Track and IND Clearance for Daretabart in High-Risk Neuroblastoma

FDA grants Fast Track Designation for Daretabart (hu1418K322A), recognising the significant unmet medical need in high-risk neuroblastoma and enabling ...

April 15, 2026 | Wednesday | News
OncoC4 Initiates Phase 1/2 Trial of Anti-SIGLEC 10 Antibody in Alzheimer’s Disease

OncoC4 Inc., a late clinical stage biopharmaceutical company, announced first participant's dosing following the clearance of the Investigational New Dru...

April 13, 2026 | Monday | News
GenScript and Mimulus Partner to Industrialize DNA Data Storage for the AI Era

The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by 2030. GenScript Biotech Co...

April 13, 2026 | Monday | News
Thermo Fisher Scientific Partners with PRECISE to Power Singapore’s Landmark SG100K Biobank Study with Integrated Proteomics

  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, \announced a strategic collaboration with Precision Health Research...

April 10, 2026 | Friday | News
NexTel Medical Corp Initiates First Phase of Global Rollout for Exosome-Based Cancer Screening Test

NexTel Medical Corp f/k/a Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery syste...

April 09, 2026 | Thursday | News
Curanex Pharmaceuticals, Inc. Expands Pipeline to Target Cancer Cachexia, Addressing Major Oncology Supportive-Care Gap

Company expands strategic focus into one of oncology’s most urgent supportive-care challenges Curanex Pharmaceuticals, Inc. (Nasdaq: CURX) (&...

April 07, 2026 | Tuesday | News
Intelligent Bio Solutions Completes Key Clinical Study, Advances Toward FDA 510(k) Clearance for Fingerprint Drug Test

Study results finalized on schedule support FDA clearance and planned U.S. commercial launch Company advances second phase of clinical program for ...

April 07, 2026 | Tuesday | News
FDA Extends EYLEA HD Dosing Interval to 20 Weeks, Advancing Long-Term Retinal Care

Approval is based on 96-week data from 2 pivotal trials showing majority of EYLEA HD patients maintained their visual and anatomic improvements with exte...

April 07, 2026 | Tuesday | News
Cipla USA Inc. Secures U.S. FDA Approval for Generic Nintedanib Capsules

- Cipla USA Inc. the wholly owned subsidiary of Cipla Limited announced final approval from the U.S. Food and Drug Administration (USFDA) for its Abbrevi...

April 06, 2026 | Monday | News
H2 Global Group Accelerates MedTech Strategy, Expands Global Ambitions with VR LIFE and Hydrogen-Based Therapeutics

H2 Global Group is strengthening its position as a European technology group connecting capital with clinically validated healthcare innovations. A prime...

April 06, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close